Filing Details
- Accession Number:
- 0001362118-21-000051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-07 15:52:26
- Reporting Period:
- 2019-09-30
- Accepted Time:
- 2021-12-07 15:52:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
948320 | Lifemd Inc. | LFMD | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 760238453 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1758339 | Bertrand Velge | C/O Lifemd, Inc. 800 Third Ave Ste 2800 New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-15 | 294,118 | $0.17 | 511,509 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-08-05 | 173,234 | $0.00 | 684,743 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2020-09-22 | 96,923 | $0.65 | 781,666 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-03 | 110,000 | $3.91 | 891,666 | No | 4 | P | Indirect | By Aliunde LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | A | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Indirect | By Aliunde LLC |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-09-30 | 2,500 | $0.00 | 2,500 | $1.15 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-12-31 | 2,500 | $0.00 | 2,500 | $1.15 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-03-31 | 2,500 | $0.00 | 2,500 | $1.20 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-06-30 | 2,500 | $0.00 | 2,500 | $1.50 |
Common Stock | Warrants to Purchase Common Stock | Acquisiton | 2020-09-22 | 100,000 | $0.00 | 100,000 | $4.65 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-09-30 | 2,500 | $0.00 | 2,500 | $7.95 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-12-31 | 2,500 | $0.00 | 2,500 | $7.00 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2021-03-31 | 2,500 | $0.00 | 2,500 | $11.98 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-06-30 | 2,500 | $0.00 | 2,500 | $11.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2019-09-30 | 2024-09-30 | No | 4 | A | Direct |
2,500 | 2019-12-31 | 2024-12-31 | No | 4 | A | Direct |
2,500 | 2021-03-31 | 2025-03-31 | No | 4 | A | Direct |
2,500 | 2020-06-30 | 2025-06-30 | No | 4 | A | Direct |
100,000 | 2020-09-22 | 2024-09-22 | No | 4 | A | Direct |
2,500 | 2020-09-30 | 2025-09-30 | No | 4 | A | Direct |
2,500 | 2020-12-31 | 2025-12-31 | No | 4 | A | Direct |
2,500 | 2021-03-31 | 2026-03-31 | No | 4 | A | Direct |
2,500 | 2021-06-30 | 2026-06-30 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 217,391 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Warrants to Purchase Common Stock | $0.28 | 2019-05-15 | 2023-05-15 | 217,391 | 217,391 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2023-05-15 | 217,391 | 217,391 | Direct |
Footnotes
- On October 14, 2020, the common stock of LFMD, Inc. had a reverse stock split 1-for-5, resulting in a decrease of the reporting person's ownership of 869,566 shares of common stock.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
- Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt.
- Issued as director's compensation.
- Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019.